U.S. flag

An official website of the United States government

NM_000212.3(ITGB3):c.856G>C (p.Gly286Arg) AND Abnormal bleeding

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 1, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000851903.1

Allele description [Variation Report for NM_000212.3(ITGB3):c.856G>C (p.Gly286Arg)]

NM_000212.3(ITGB3):c.856G>C (p.Gly286Arg)

Genes:
LOC130061045:ATAC-STARR-seq lymphoblastoid active region 12309 [Gene]
ITGB3:integrin subunit beta 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.32
Genomic location:
Preferred name:
NM_000212.3(ITGB3):c.856G>C (p.Gly286Arg)
Other names:
NM_000212.2(ITGB3):c.856G>C; p.Gly286Arg
HGVS:
  • NC_000017.11:g.47287148G>C
  • NG_008332.2:g.38307G>C
  • NM_000212.3:c.856G>CMANE SELECT
  • NP_000203.2:p.Gly286Arg
  • NP_000203.2:p.Gly286Arg
  • LRG_481t1:c.856G>C
  • LRG_481:g.38307G>C
  • LRG_481p1:p.Gly286Arg
  • NC_000017.10:g.45364514G>C
  • NM_000212.2:c.856G>C
Protein change:
G286R
Links:
dbSNP: rs1199275720
NCBI 1000 Genomes Browser:
rs1199275720
Molecular consequence:
  • NM_000212.3:c.856G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Abnormal bleeding
Identifiers:
MedGen: C1458140; Human Phenotype Ontology: HP:0001892

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000899968NIHR Bioresource Rare Diseases, University of Cambridge - ThromboGenomics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Feb 1, 2019)
unknownresearch

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
South-Asianunknownyes1not providednot provided1not providedresearch

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders.

Downes K, Megy K, Duarte D, Vries M, Gebhart J, Hofer S, Shamardina O, Deevi SVV, Stephens J, Mapeta R, Tuna S, Al Hasso N, Besser MW, Cooper N, Daugherty L, Gleadall N, Greene D, Haimel M, Martin H, Papadia S, Revel-Vilk S, Sivapalaratnam S, et al.

Blood. 2019 Dec 5;134(23):2082-2091. doi: 10.1182/blood.2018891192.

PubMed [citation]
PMID:
31064749
PMCID:
PMC6993014

Details of each submission

From NIHR Bioresource Rare Diseases, University of Cambridge - ThromboGenomics, SCV000899968.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1South-Asian1not providednot providedresearch PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyes1not providednot provided1not providednot providednot provided

Last Updated: Oct 14, 2023